Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis-Reference-Cited by-同舟云学术

Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis

Published:2015-02-06 Issue:2 Volume:17 Page:163-173
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Stevens D.R.¹,Sawinski D.²,Blumberg E.³,Galanakis N.⁴,Bloom R.D.²,Trofe-Clark J.¹²

Affiliation:

1. Department of Pharmacy Services; Hospital of the University of Pennsylvania; Philadelphia Pennsylvania USA

2. Renal Electrolyte and Hypertension Division; Department of Medicine; Perelman School of Medicine; University of Pennsylvania; Philadelphia Pennsylvania USA

3. Infectious Disease Division; Department of Medicine; Perelman School of Medicine; University of Pennsylvania; Philadelphia Pennsylvania USA

4. Philadelphia College of Pharmacy; University of the Sciences; Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12349/fullpdf

Reference36 articles.

1. Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment;Beam;Curr Infect Dis Rep,2012

2. Infection in solid-organ transplant recipients;Fishman;N Engl J Med,2007

3. Direct and indirect effects of cytomegalovirus: can we prevent them?;Razonable;Enferm Infecc Microbiol Clin,2010

4. The risk of cytomegalovirus recurrence after kidney transplantation;Helantera;Transpl Int,2011

5. Pretransplantation assessment of the risk of lymphoproliferative disorder;Walker;Clin Infect Dis,1995

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update;Transplantation Reviews;2024-12

2. Management of cytomegalovirus infection after liver transplantation;World Journal of Transplantation;2024-09-18

3. Management of cytomegalovirus infections – Swedish recommendations 2023;Infectious Diseases;2024-08-26

4. Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults;British Journal of Clinical Pharmacology;2024-06-18

5. Therapeutic Myths in Solid Organ Transplantation Infectious Diseases;Open Forum Infectious Diseases;2024-06-15